Elata Biosciences co-founder Andreas Melhede is pioneering the integration of brain data with blockchain through decentralized science (DeSci). This approach contrasts with centralized brain-computer interface (BCI) projects like Neuralink, which focus on enhancing human capabilities. Melhede emphasizes the importance of decentralization to maintain privacy and user consent, allowing individuals to own and control their neural data. By converting neural signals into secure digital data on decentralized platforms, DeSci aims to protect user autonomy and promote diverse development in brain interface technologies.